|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 92, 583-593, Copyright © 1986 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
F Okamoto, BS Allen, GD Buckberg, H Young, H Bugyi and J Leaf
This study tests the hypothesis that improved muscle salvage after
prolonged ischemia (4 hours) occurs when the substrate-enriched blood
cardioplegic solution is markedly hyperglycemic (greater than 400 mg/dl)
and markedly hyperosmotic (greater than 400 mOsm). Thirty-five dogs
underwent 4 hours of occlusion of the left anterior descending coronary
artery and reperfusion during total vented bypass with substrate-enriched
blood cardioplegic solution, in which the glucose concentration and
osmolarity were varied in relation to one another. Spontaneous systolic
shortening recovered consistently (31 +/- 6%) only when glucose was greater
than 400 mg/dl and osmolarity was greater than 400 mOsm. The least recovery
occurred (only one of six dogs recovering spontaneous shortening) when
cardioplegic glucose was greater than 400 mg/dl and osmolarity was greater
than 400 mOsm. Regional segments reperfused with our standard
substrate-enriched blood cardioplegic solution had lower transmural flow
rates following reperfusion (56 versus 87 ml/100 gm/min, p less than 0.05),
markedly reduced mitochondrial State 3 and State 4 respiration in
epicardial and endocardial muscle (p less than 0.05), and the most
extensive histochemical evidence of damage (63% area of nonstaining versus
area at risk, p less than 0.05). We conclude that markedly increased levels
of osmolarity (greater than 400 mOsm) and glucose (greater than 400 mg/dl)
improve the capacity of substrate-enriched blood cardioplegic solution to
salvage myocardium after prolonged ischemia.
ARTICLES
Reperfusate composition: interaction of marked hyperglycemia and marked hyperosmolarity in allowing immediate contractile recovery after four hours of regional ischemia
This article has been cited by other articles:
![]() |
I. George and M. C. Oz Myocardial Revascularization after Acute Myocardial Infarction Card. Surg. Adult, January 1, 2008; 3(2008): 669 - 696. [Full Text] |
||||
![]() |
T. Doenst, W. Bothe, and F. Beyersdorf Therapy with insulin in cardiac surgery: controversies and possible solutions Ann. Thorac. Surg., February 1, 2003; 75(2): S721 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Lee, W. Ting, and M. C. Oz Myocardial Revascularization after Acute Myocardial Infarction Card. Surg. Adult, January 1, 2003; 2(2003): 639 - 658. [Full Text] |
||||
![]() |
G. D. Buckberg Substrate enriched warm blood cardioplegia reperfusion: an alternate view Ann. Thorac. Surg., February 1, 2000; 69(2): 334 - 335. [Full Text] [PDF] |
||||
![]() |
F. Beyersdorf Protection of Evolving Myocardial Infarction and Failed PTCA Ann. Thorac. Surg., September 1, 1995; 60(3): 833 - 838. [Abstract] [Full Text] |
||||
![]() |
T. Asai, E. A. Grossi, M. LeBoutillier III, M. A. Parish, F. G. Baumann, F. C. Spencer, S. B. Colvin, and A. C. Galloway Resuscitative retrograde blood cardioplegiaAre amino acids or continuous warm techniques necessary? J. Thorac. Cardiovasc. Surg., February 1, 1995; 109(2): 242 - 248. [Abstract] [Full Text] |
||||
![]() |
W. R. Chitwood Jr and C. L. Wixon Update in Myocardial Protection Ann. Thorac. Surg., January 1, 1995; 59(1): 253 - 254. [Full Text] |
||||
![]() |
G. D. Buckberg Normothermic blood cardioplegiaAlternative or adjunct? J. Thorac. Cardiovasc. Surg., March 1, 1994; 107(3): 860 - 867. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |